Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

HocusLocus LLC
Profile last edited on: 11/22/2017      CAGE: 4ZWK2      UEI: L9JLQACKL9U3

Business Identifier: Molecular tools and therapeutics
Year Founded
2008
First Award
2011
Latest Award
2018
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

170 Chestnut Street
Albany, NY 12210
   (518) 331-1133
   info@hocuslocus.com
   www.hocuslocus.com
Location: Single
Congr. District: 20
County: Albany

Public Profile

HocusLocus LLC, spun out of SUNY Polytechnic Institute’s College of Nanoscale Science and Engineering, develops molecular tools and therapeutics based on the company's structurally interacting RNA (sxRNA) platform technology. The firm's sxRNA technology acts like a nano-switch that can turn on protein production in specific cells, tissues and disease states. Applications for this technology include Cell Line Development and Antiviral Therapy.

Extent of SBIR involvement

User Avatar
Phase I Awards
5
Phase II Awards
1
Conversion Rate
20.00%
Phase I Dollars
$1,193,166
Phase II Dollars
$1,427,252
Total Awarded
$2,620,418

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2018 2 NIH $1,652,252
Project Title: A Novel Approach to Purifying Ipsc Derived Cell Cultures
2015 1 NSF $225,000
Project Title: Improving Biomanufacturing in Chinese Hampster Ovary Cells Using Structurally Interacting RNA (sxRNA)
2015 1 NIH $225,000
Project Title: Sxrna-Based Antiviral Approach Targeting Epstein-Barr Virus
2014 1 NIH $224,609
Project Title: Using Structuring Interacting Rnas (SXRNAS) as Microrna Inhibitors
2011 1 NIH $293,557
Project Title: In-Vivo Mirna Detection Using Structurally Interacting RNA (Sxrna)

Key People / Management

  Scott A Tenenbaum -- President

  Sumita Bhaduri-Mcintosh

  Ted Eveleth -- Partner

  James Keith

  Susan T Sharfstein

Company News

Jun 15 2015
SUNY Poly biotech company awarded federal grant to kill infected cells
Nov 08 2013
SUNY: HocusLocus, LLC., the University at Albany and the College of Nanoscale Science and Engineering